Boston Scientific Corporation (LON: 0HOY)

London flag London · Delayed Price · Currency is GBP · Price in USD
101.25
+0.24 (0.24%)
Jan 22, 2025, 7:13 PM BST
66.41%
Market Cap 120.04B
Revenue (ttm) 11.87B
Net Income (ttm) 1.34B
Shares Out n/a
EPS (ttm) 0.90
PE Ratio 89.73
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 133,002
Average Volume 13,242
Open 101.25
Previous Close 101.01
Day's Range 100.49 - 101.63
52-Week Range 47.37 - 101.63
Beta 0.80
RSI 77.62
Earnings Date Jan 31, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, c... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 48,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HOY
Full Company Profile

Financial Performance

In 2023, Boston Scientific's revenue was $14.24 billion, an increase of 12.29% compared to the previous year's $12.68 billion. Earnings were $1.57 billion, an increase of 144.55%.

Financial numbers in USD Financial Statements

News

Top 4 Health Care Stocks You May Want To Dump In Q1

As of Jan. 21, 2025, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

1 day ago - Benzinga

Boston Scientific (BSX) Receives Preliminary Approval for Shareholder Derivative Settlement

Boston Scientific (BSX) Receives Preliminary Approval for Shareholder Derivative Settlement

6 days ago - GuruFocus

Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation

First phase of ADVANTAGE AF clinical trial achieves safety and effectiveness endpoints for treatment of drug-resistant, symptomatic, persistent atrial fibrillation with the FARAPULSE™ Pulsed Field Abl...

6 days ago - PRNewsWire

Boston Scientific Jumps Ahead of Earnings

Boston Scientific Corporation (BSX) shares rise on acquisitions – earnings due in early February.

7 days ago - FX Empire

We have the largest venture portfolio in medtech, says Boston Scientific CEO Mike Mahoney

Boston Scientific Chair and CEO Mike Mahoney joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare COnference to talk its outlook for 2025, its venture portfolio, and more.

9 days ago - CNBC

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

The Investment Committee discuss some stocks on the move today.

12 days ago - CNBC Television

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

The Investment Committee discuss some stocks on the move today.

12 days ago - CNBC

Boston Scientific Completes Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio

Boston Scientific Completes Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio

14 days ago - GuruFocus

Mixed gains/losses in the major indices

The major US indices are ending the day mixed with the Dow and S&P higher, and the Nasdaq and Russell 2000 lower. Trading conditions were up and down volatile. Tomorrow the stock markets will be close...

14 days ago - Forexlive

Final Trades: Apollo, UnitedHealth, Boston Scientific and the IYF

The Investment Committee give you their top stocks to watch for the second half.

14 days ago - CNBC Television

Final Trades: Apollo, UnitedHealth, Boston Scientific and the IYF

The Investment Committee give you their top stocks to watch for the second half.

14 days ago - CNBC

J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

14 days ago - Investor's Business Daily

Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal

On Wednesday, Boston Scientific Corporation (NYSE: BSX) agreed to acquire Bolt Medical, Inc. , the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and perip...

14 days ago - Benzinga

Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal

On Wednesday, Boston Scientific Corporation BSX agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and peripheral arte...

14 days ago - Benzinga

Boston Scientific to Acquire Bolt Medical for $443 Million in Expansion of Cardiovascular Portfolio

Boston Scientific to Acquire Bolt Medical for $443 Million in Expansion of Cardiovascular Portfolio

14 days ago - GuruFocus

Boston Scientific (BSX) Reaches New High Following Acquisition Announcement

Boston Scientific (BSX) Reaches New High Following Acquisition Announcement

14 days ago - GuruFocus

Boston Scientific Surges Into Buy Zone On $900 Million Takeover Of Bolt Medical

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.

14 days ago - Investor's Business Daily

Boston Scientific announces acquisition of the remaining stake in Bolt Medical

Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own.

14 days ago - Seeking Alpha

Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.

Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company's strategy to address coronary and peripheral disease MARLBOROUGH...

14 days ago - PRNewsWire

Healthcare sector's 2024 gainers and losers: Intuitive Surgical, Boston Scientific tops chart

Learn about the performance of the healthcare sector in 2024, top performers, bottom performers, analyst expectations, and quantitative measures.

16 days ago - Seeking Alpha

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.

19 days ago - Benzinga

Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 9.12% on an annualized basis producing an average annual return of 20.37%. Currently, Boston Scientific has a marke...

20 days ago - Benzinga

Boston Scientific Corp (BSX) Announces Participation in J.P. ...

Boston Scientific Corp (BSX) Announces Participation in J.P. Morgan Healthcare Conference and Q4 2024 Results Call

20 days ago - GuruFocus

Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results

MARLBOROUGH, Mass. , Jan. 2, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 43rd Annual J.P.

20 days ago - PRNewsWire